Astex Therapeutics Ltd

General

Total Cases8

Active Cases8

Patents91

CourtsD. Delaware D. New Jersey

TypeOperating Company

Elite Ratings

--

--

--

--

Ratings

Experience

Grade

Trend

DCT

--

--

--

PTAB

--

--

--

CAFC

--

--

--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered	Case	Description
11/04/24	Janssen Pharmaceutica NV v. Natco Pharma Ltd 2:23-CV-03959 ( D. NJ )	ORDER granting Plaintiffs' [70] Consent Motion for Leave to Amend Their L. Pat. R.3.6(g) Disclosure of Infringement Contentions. The proposed amended documents attached as Exhibits 1-2 to the Stewart declaration accompanying the motion are hereby deemed to supersede, respectively, Plaintiffs' L. Pat. R. 3.6(g) Disclosure of Infringement Contentions and Exhibit A thereto, both served 8/30/2024. Exhibits B-D to Plaintiffs' L. Pat. R. 3.6(g) Disclosure of Infringement Contentions, served 8/30/2024, remain operative. Signed by Magistrate Judge Jose R. Almonte on 11/4/2024. (wh) (Entered: 11/04/2024) ORDER granting Plaintiffs' [70] Consent Motion for Leave to Amend Their L. Pat. R.3.6(g) Disclosure of Infringement Contentions. The proposed amended documents attached as Exhibits 1-2 to the Stewart declaration accompanying the motion are hereby deemed to supersede, respectively, Plaintiffs' L. Pat. R. 3.6(g) Disclosure of Infringement Contentions and Exhibit A thereto, both served 8/30/2024. Exhibits B-D to Plaintiffs' L. Pat. R. 3.6(g) Disclosure of Infringement Contentions, served 8/30/2024, remain operative. Signed by Magistrate Judge Jose R. Almonte on 11/4/2024. (wh) (Entered: 11/04/2024)
11/04/24	Janssen Pharmaceutica NV v. Natco Pharma Ltd 2:23-CV-03959 ( D. NJ )	LETTER ORDER granting Defendant Natco Pharma Ltd.'s [72] Letter requesting that the Court permit the withdrawal of the pro hac vice admission of W. REID MORRIS, Esq., as counsel for Natco. W. REID MORRIS terminated. Signed by Magistrate Judge Jose R. Almonte on 11/4/2024. (wh) (Entered: 11/04/2024)
11/01/24	Janssen Pharmaceutica NV v. Natco Pharma Ltd 2:23-CV-03959 ( D. NJ )	RESPONSE to Motion filed by All Defendants re [70] MOTION to Amend/Correct Infringement Contentions (on consent) via Letter from E. Abraham to Judge Almonte (ABRAHAM, ERIC) (Entered: 11/01/2024)
11/01/24	Janssen Pharmaceutica NV v. Natco Pharma Ltd 2:23-CV-03959 ( D. NJ )	Letter from William Murtha to the Honorable Jose R. Almonte,U.S.M.J., with proposed Order. (MURTHA, WILLIAM) (Entered: 11/01/2024)
11/01/24	Janssen Pharmaceutica NV v. Natco Pharma Ltd 2:23-CV-03959 ( D. NJ )	Set Deadlines as to [70] MOTION to Amend/Correct Infringement Contentions (on consent). Motion set for 12/2/2024 before Magistrate Judge Jose R. Almonte. Unless otherwise directed by the Court, this motion will be decided on the papers and no appearances are required. Note that this is an automatically generated message from the Clerk`s Office and does not supersede any previous or subsequent orders from the Court. (wh) (Entered: 11/01/2024) Set Deadlines as to [70] MOTION to Amend/Correct Infringement Contentions (on consent). Motion set for 12/2/2024 before Magistrate Judge Jose R. Almonte. Unless otherwise directed by the Court, this motion will be decided on the papers and no appearances are required. Note that this is an automatically generated message from the Clerk`s Office and does not supersede any previous or subsequent orders from the Court. (wh) (Entered: 11/01/2024)
10/31/24	Janssen Pharmaceutica NV v. Natco Pharma Ltd 2:23-CV-03959 ( D. NJ )	BRIEF in Support filed by All Plaintiffs re [70] MOTION to Amend/Correct Infringement Contentions (on consent) (Attachments: # [1] Exhibit 1, # [2] Exhibit 2, # [3] Exhibit 3, # [4] Exhibit 4, # [5] Exhibit 5, # [6] Exhibit 6, # [7] Exhibit 9, # [8] Exhibit 11, # [9] Exhibit 12, # [10] Exhibit 15)(MILLER, KEITH)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 10/31/2024) BRIEF in Support filed by All Plaintiffs re [70] MOTION to Amend/Correct Infringement Contentions (on consent) (Attachments: # [1] Exhibit 1, # [2] Exhibit 2, # [3] Exhibit 3, # [4] Exhibit 4, # [5] Exhibit 5, # [6] Exhibit 6, # [7] Exhibit 9, # [8] Exhibit 11, # [9] Exhibit 12, # [10] Exhibit 15)(MILLER, KEITH)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 10/31/2024)
10/31/24	Janssen Pharmaceutica NV v. Natco Pharma Ltd 2:23-CV-03959 ( D. NJ )	MOTION to Amend/Correct Infringement Contentions (on consent) by All Plaintiffs. (Attachments: # [1] Text of Proposed Order, # [2] Declaration of Gwen Hochman Stewart, # [3] Exhibit 1 (sealed), # [4] Exhibit 2 (sealed), # [5] Exhibit 3 (sealed), # [6] Exhibit 4 (sealed), # [7] Exhibit 5 (sealed), # [8] Exhibit 6 (sealed), # [9] Exhibit 7, # [10] Exhibit 8, # [11] Exhibit 9 9sealed), # [12] Exhibit 10, # [13] Exhibit 11 (sealed), # [14] Exhibit 12 (sealed), # [15] Exhibit 13, # [16] Exhibit 14, # [17] Exhibit 15 (sealed), # [18] Exhibit 16)(MILLER, KEITH) (Entered: 10/31/2024) MOTION to Amend/Correct Infringement Contentions (on consent) by All Plaintiffs. (Attachments: # [1] Text of Proposed Order, # [2] Declaration of Gwen Hochman Stewart, # [3] Exhibit 1 (sealed), # [4] Exhibit 2 (sealed), # [5] Exhibit 3 (sealed), # [6] Exhibit 4 (sealed), # [7] Exhibit 5 (sealed), # [8] Exhibit 6 (sealed), # [9] Exhibit 7, # [10] Exhibit 8, # [11] Exhibit 9 9sealed), # [12] Exhibit 10, # [13] Exhibit 11 (sealed), # [14] Exhibit 12 (sealed), # [15] Exhibit 13, # [16] Exhibit 14, # [17] Exhibit 15 (sealed), # [18] Exhibit 16)(MILLER, KEITH) (Entered: 10/31/2024)
10/24/24	Novartis Pharmaceuticals Corp v. MSN Pharmaceuticals Inc 1:24-CV-01193 ( D. DE )	Summons Issued as to MSN Laboratories Pvt. Ltd. on 10/23/2024; MSN Pharmaceuticals Inc. on 10/23/2024. (Attachments: # [1] Summons Issued)(oam) (Entered: 10/24/2024)
10/24/24	Novartis Pharmaceuticals Corp v. MSN Pharmaceuticals Inc 1:24-CV-01193 ( D. DE )	Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Otsuka America, Inc., Other Affiliate Otsuka Holdings Co., Ltd., Other Affiliate Otsuka Pharmaceutical Co., Ltd. for Astex Therapeutics Ltd. filed by Astex Therapeutics Ltd. (oam) (Entered: 10/24/2024)
10/24/24	Novartis Pharmaceuticals Corp v. MSN Pharmaceuticals Inc 1:24-CV-01193 ( D. DE )	Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation filed by Novartis Pharmaceuticals Corporation. (oam) (Entered: 10/24/2024)